Orthofix launches new bioactive synthetic graft
Orthofix earned FDA 510(k) clearance for its OsteoCove advance bioactive synthetic graft, the company said Oct. 12.
Source: beckersspine.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Trip Configurations. Real-time updates on events, politics, business and more.